These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 8427586)

  • 1. Transcriptional attenuation of PIM-1 gene.
    Nagarajan L; Narayana L
    Biochem Biophys Res Commun; 1993 Jan; 190(2):435-9. PubMed ID: 8427586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. pim-1 proto-oncogene expression in anti-CD3-mediated T cell activation is associated with protein kinase C activation and is independent of Raf-1.
    Wingett D; Long A; Kelleher D; Magnuson NS
    J Immunol; 1996 Jan; 156(2):549-57. PubMed ID: 8543805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitous expression and cell cycle regulation of the protein kinase PIM-1.
    Liang H; Hittelman W; Nagarajan L
    Arch Biochem Biophys; 1996 Jun; 330(2):259-65. PubMed ID: 8660654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human Pim-1 gene is selectively transcribed in different hemato-lymphoid cell lines in spite of a G + C-rich housekeeping promoter.
    Meeker TC; Loeb J; Ayres M; Sellers W
    Mol Cell Biol; 1990 Apr; 10(4):1680-8. PubMed ID: 2181282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability changes in pim-1 proto-oncogene mRNA after mitogen stimulation of normal lymphocytes.
    Wingett D; Reeves R; Magnuson NS
    J Immunol; 1991 Nov; 147(10):3653-9. PubMed ID: 1940364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting PIM kinases impairs survival of hematopoietic cells transformed by kinase inhibitor-sensitive and kinase inhibitor-resistant forms of Fms-like tyrosine kinase 3 and BCR/ABL.
    Adam M; Pogacic V; Bendit M; Chappuis R; Nawijn MC; Duyster J; Fox CJ; Thompson CB; Cools J; Schwaller J
    Cancer Res; 2006 Apr; 66(7):3828-35. PubMed ID: 16585210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels.
    Morishita D; Katayama R; Sekimizu K; Tsuruo T; Fujita N
    Cancer Res; 2008 Jul; 68(13):5076-85. PubMed ID: 18593906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the pim-1 protooncogene: differential inducibility between alpha/beta- and gamma/delta-T cells and B cells.
    Wingett D; Stone D; Davis WC; Magnuson NS
    Cell Immunol; 1995 Apr; 162(1):123-30. PubMed ID: 7704900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in pim-1 and c-myc expression associated with sodium butyrate-induced growth factor dependency in autonomous rat Nb2 lymphoma cells.
    Buckley AR; Leff MA; Buckley DJ; Magnuson NS; de Jong G; Gout PW
    Cell Growth Differ; 1996 Dec; 7(12):1713-21. PubMed ID: 8959340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.
    Zhou D; Masri S; Ye JJ; Chen S
    Gene; 2005 Nov; 361():89-100. PubMed ID: 16181749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the human PIM-1 gene: a putative proto-oncogene coding for a tissue specific member of the protein kinase family.
    Meeker TC; Nagarajan L; ar-Rushdi A; Rovera G; Huebner K; Croce CM
    Oncogene Res; 1987 Jun; 1(1):87-101. PubMed ID: 3329711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pim-1 protein expression is regulated by its 5'-untranslated region and translation initiation factor elF-4E.
    Hoover DS; Wingett DG; Zhang J; Reeves R; Magnuson NS
    Cell Growth Differ; 1997 Dec; 8(12):1371-80. PubMed ID: 9419425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic organization and promoter analysis of the mouse ADP-ribosylarginine hydrolase gene.
    Aoki K; Kato J; Shoemaker MT; Moss J
    Gene; 2005 May; 351():83-95. PubMed ID: 15893437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis.
    Wang Z; Bhattacharya N; Weaver M; Petersen K; Meyer M; Gapter L; Magnuson NS
    J Vet Sci; 2001 Dec; 2(3):167-79. PubMed ID: 12441685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and characterization of the human PIM-1 gene: a putative oncogene related to the protein kinases.
    Meeker TC; Nagarajan L; ar-Rushdi A; Croce CM
    J Cell Biochem; 1987 Oct; 35(2):105-12. PubMed ID: 3429489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of AKT1 expression by beta-catenin/Tcf/Lef signaling in colorectal cancer cells.
    Dihlmann S; Kloor M; Fallsehr C; von Knebel Doeberitz M
    Carcinogenesis; 2005 Sep; 26(9):1503-12. PubMed ID: 15888491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zinc finger protein GFI-1 has low oncogenic potential but cooperates strongly with pim and myc genes in T-cell lymphomagenesis.
    Schmidt T; Karsunky H; Gau E; Zevnik B; Elsässer HP; Möröy T
    Oncogene; 1998 Nov; 17(20):2661-7. PubMed ID: 9840930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional induction of pim-1 protein kinase gene expression by interferon gamma and posttranscriptional effects on costimulation with steel factor.
    Yip-Schneider MT; Horie M; Broxmeyer HE
    Blood; 1995 Jun; 85(12):3494-502. PubMed ID: 7540064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pim kinases are upregulated during Epstein-Barr virus infection and enhance EBNA2 activity.
    Rainio EM; Ahlfors H; Carter KL; Ruuska M; Matikainen S; Kieff E; Koskinen PJ
    Virology; 2005 Mar; 333(2):201-6. PubMed ID: 15721354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein.
    Hahm KB; Cho K; Lee C; Im YH; Chang J; Choi SG; Sorensen PH; Thiele CJ; Kim SJ
    Nat Genet; 1999 Oct; 23(2):222-7. PubMed ID: 10508522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.